The dysregulation of miRNAs in cancer can occur through multiple mechanisms such as genetic mutations, epigenetic changes, and alterations in the biogenesis pathways. For example, the miR-34a is often silenced in cancer due to hypermethylation of its promoter region, leading to reduced expression of this tumor-suppressing miRNA.
